Are you Dr. Liu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
850 W Baraga Ave
Marquette, MI 49855Phone+1 800-288-8325
Summary
- Dr. Chunming Liu, MD is a board certified pathologist in Marquette, Michigan. He is currently licensed to practice medicine in Michigan, Florida, and Kentucky. He is affiliated with Oscar G. Johnson Department of Veterans Affairs Medical Facility, UP Health System - Portage, and MyMichigan Medical Center Sault.
Education & Training
University of Louisville School of MedicineFellowship, Blood Banking/Transfusion Medicine, 2005 - 2006- University of Louisville School of MedicineFellowship, Cytopathology, 2004 - 2005
- University of Louisville School of MedicineResidency, Pathology-Anatomic and Clinical, 2000 - 2004
Tongji Medical UniversityClass of 1982
Certifications & Licensure
FL State Medical License 2005 - 2026
KY State Medical License 2004 - 2025
MI State Medical License 2005 - 2025- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Genomic screening methodology not requiring barcoding: Single nucleotide polymorphism-based, mixed-cell screening (SMICS).Zhuwei Zhang, Xi Chen, Wen Zhang, Jinpeng Liu, Yanqi Xie
Genomics. 2023-09-01 - 6 citationsA Benzenesulfonamide-Based Mitochondrial Uncoupler Induces Endoplasmic Reticulum Stress and Immunogenic Cell Death in Epithelial Ovarian Cancer.Fangfang Bi, Ziyan Jiang, Wonmin Park, Tobias M.P. Hartwich, Zhiping Ge
Molecular Cancer Therapeutics. 2021-10-08 - 5 citationsPotent Synergistic Effect on C-Myc-Driven Colorectal Cancers Using a Novel Indole-Substituted Quinoline with a Plk1 Inhibitor.Yanqi Xie, Wen Zhang, Lichao Guo, Liliia M. Kril, Kristin L. Begley
Molecular Cancer Therapeutics. 2021-08-10
